This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of allergy to drugs, medicaments and biological substances
Z21_PERSONAL_HISTORY_ALLERGY_DRUGS_MEDICAM_BIOLO_SUBST
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
496 |
4. Check minimum number of eventsNone |
496 |
5. Include endpointsNone |
496 |
6. Filter based on genotype QC (FinnGen only) |
462 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Personal history of allergy to drugs, medicaments and biological substances
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 462 | 335 | 127 |
| Unadjusted period prevalence (%) | 0.10 | 0.12 | 0.06 |
| Median age at first event (years) | 53.29 | 52.14 | 56.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 475
- Matched controls
- 4750
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
+∞
285.1
244
*
J32.4
ICD-10 Finland
Chronic pansinusitis
73.3
271.8
151
30
J33.0
ICD-10 Finland
Polyp of nasal cavity
48.6
265.8
164
51
J33.8
ICD-10 Finland
Other polyp of sinus
49.0
218.3
132
37
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
38.2
218.1
143
53
XQ800
NOMESCO Finland
Prick test
17.5
198.5
201
191
DHB20
NOMESCO Finland
Polypectomy of internal nose
65.5
184.0
103
20
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
18.3
176.3
164
133
J45.1
ICD-10 Finland
Nonallergic asthma
15.3
167.7
178
179
C01CA24
ATC
epinephrine; parenteral
13.3
151.8
177
203
UDH02
NOMESCO Finland
Rhinopharyngoscopy
13.3
142.5
162
178
J45.0
ICD-10 Finland
Predominantly allergic asthma
10.3
129.6
189
287
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
8.9
129.1
259
565
R03DC03
ATC
montelukast; oral
8.7
126.3
253
549
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
17.8
125.3
111
80
TDM10
NOMESCO Finland
Puncture of maxillary antrum
15.2
120.7
118
101
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
10.6
117.3
157
212
DPA30
NOMESCO Finland
Sphenotomy
50.9
112.8
66
15
J45.9
ICD-10 Finland
Asthma, unspecified
7.5
107.7
240
567
J33.9
ICD-10 Finland
Nasal polyp, unspecified
53.8
98.8
57
12
R01AD08
ATC
fluticasone; nasal
6.7
94.3
301
974
R03BB04
ATC
tiotropium bromide; inhalant
9.2
91.9
132
191
Z88.8
ICD-10 Finland
Personal history of allergy to other drugs, medicaments and biological substances
+∞
86.1
80
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
14.2
85.6
84
71
ZXA10
NOMESCO Finland
Bilateral
6.4
80.4
184
430
R01AD05
ATC
budesonide; nasal
7.6
72.0
119
199
H02AB07
ATC
prednisone; oral
6.3
70.9
151
326
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
9.1
68.2
93
124
J45
ICD-10 Finland
Asthma
6.4
66.5
135
277
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.5
66.5
133
269
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
23.6
66.5
49
23
H02AB04
ATC
methylprednisolone; systemic
5.9
65.5
149
340
H02AB06
ATC
prednisolone; systemic
5.5
65.3
349
1589
R03BA02
ATC
budesonide; inhalant
5.1
64.4
196
574
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.4
59.5
153
386
Z88.1
ICD-10 Finland
Personal history of allergy to other antibiotic agents
+∞
58.6
55
*
T78.4
ICD-10 Finland
Allergy, unspecified
8.6
56.0
78
106
J46
ICD-10 Finland
Status asthmaticus
12.3
55.7
58
53
D11AH05
ATC
dupilumab; topical
126.6
53.1
56
5
R03AK08
ATC
formoterol and beclometasone; inhalant
7.9
52.6
79
117
395
Kela drug reimbursment
Dupilumab
121.5
51.0
54
5
R03AC12
ATC
salmeterol; inhalant
9.7
50.6
63
74
R03AC02
ATC
salbutamol; inhalant
5.5
49.9
392
2204
R03BA05
ATC
fluticasone; inhalant
4.3
49.3
181
595
R03DA04
ATC
theophylline; systemic, rectal
9.2
47.2
61
75
WX002
NOMESCO Finland
Sedation and analgesia
4.4
44.6
144
427
ZXC95
NOMESCO Finland
Use of surgical navigator
17.6
43.1
36
22
R03AK07
ATC
formoterol and budesonide; inhalant
3.8
43.0
192
714
ZXD10
NOMESCO Finland
Scheduled procedure
3.6
42.5
255
1148
R03AC13
ATC
formoterol; inhalant
7.2
42.2
68
108
Z2221
NOMESCO Finland
Medical doctor
3.7
42.1
220
905
R06AE07
ATC
cetirizine; oral
3.8
42.1
318
1655
ZXE00
NOMESCO Finland
One hour or less
3.6
41.8
265
1232
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
41.3
185
687
Z3231
NOMESCO Finland
Registered nurse
3.6
40.7
203
807
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.8
40.3
109
280
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
7.6
39.6
60
89
J45.8
ICD-10 Finland
Mixed asthma
9.6
39.1
48
55
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
38.4
236
1062
R03AK11
ATC
formoterol and fluticasone; inhalant
10.6
36.1
41
42
WX402
NOMESCO Finland
General anaesthesia
3.5
35.2
169
646
R06AX27
ATC
desloratadine; oral
3.2
34.2
239
1142
R03BA08
ATC
ciclesonide; inhalant
4.6
33.6
93
241
R01AD09
ATC
mometasone; nasal
3.3
33.2
315
1783
R06AE09
ATC
levocetirizine; oral
3.7
33.0
134
458
Z88.0
ICD-10 Finland
Personal history of allergy to penicillin
345.8
32.3
32
*
R01AD58
ATC
fluticasone, combinations; nasal
3.1
31.2
206
941
Z96.1
ICD-10 Finland
Presence of intraocular lens
7.5
30.7
46
67
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.5
30.6
53
90
R96
ICPC
Asthma
4.2
30.2
91
251
ZXD20
NOMESCO Finland
Day surgery
3.8
29.8
108
340
R03AC03
ATC
terbutaline; inhalant
3.6
29.4
119
403
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
29.3
259
1378
J33
ICD-10 Finland
Nasal polyp
31.6
29.0
38
13
R01AD12
ATC
fluticasone furoate; nasal
2.9
28.2
234
1196
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.1
28.0
39
52
R06AX13
ATC
loratadine; oral
3.3
27.2
133
505
Z88.9
ICD-10 Finland
Personal history of allergy to unspecified drugs, medicaments and biological substances
286.5
27.0
27
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.5
26.8
115
402
J01FA06
ATC
roxithromycin; oral
2.8
26.7
243
1295
N02AX02
ATC
tramadol; systemic, rectal
2.8
26.6
249
1344
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
26.2
156
662
J01MA14
ATC
moxifloxacin; systemic
4.3
25.6
73
192
DHB50
NOMESCO Finland
Turbinoplasty
7.4
25.4
38
55
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
7.4
25.4
38
55
Z3226
NOMESCO Finland
Physiotherapist
3.2
25.2
129
501
R4110
NOMESCO Finland
Physiotherapy
2.8
24.9
176
816
M01AE01
ATC
ibuprofen; systemic, rectal
0.3
24.2
316
4042
XQ820
NOMESCO Finland
Exposure to medicinal substance
44.0
23.9
29
7
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.2
22.8
31
40
J01FF01
ATC
clindamycin; systemic
2.7
22.7
174
835
R03BA01
ATC
beclometasone; inhalant
3.3
22.6
103
371
R03DC01
ATC
zafirlukast; oral
9.2
21.7
27
31
J01AA02
ATC
doxycycline; systemic
3.5
21.7
409
3027
L50.9
ICD-10 Finland
Urticaria, unspecified
5.1
21.5
48
103
Z88.4
ICD-10 Finland
Personal history of allergy to anaesthetic agent
+∞
21.0
20
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.5
20.9
35
57
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
19.4
20.7
31
17
4222
FHL
Endonasal etmoidectomy
34.3
20.4
26
8
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.5
20.1
183
944
R06AX22
ATC
ebastine; oral
2.8
19.7
129
565
J01FA09
ATC
clarithromycin; systemic
2.4
19.6
206
1132
R02
ICPC
Shortness of breath/dyspnoea
3.1
19.3
96
362
ZX112
NOMESCO Finland
Subcutaneous
7.6
19.3
28
39
ZXA05
NOMESCO Finland
Left side
2.7
19.2
132
593
R06.0
ICD-10 Finland
Dyspnoea
2.5
18.7
157
775
R03DX09
ATC
mepolizumab; parenteral
197.5
18.7
19
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.9
18.5
34
61
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
18.2
131
600
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
54.8
18.1
21
*
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
8.1
17.6
24
31
R01BA52
ATC
pseudoephedrine, combinations; oral
2.4
17.5
181
978
J30.3
ICD-10 Finland
Other allergic rhinitis
4.6
17.3
43
101
J01MA02
ATC
ciprofloxacin; systemic
2.3
17.0
197
1114
J01MA12
ATC
levofloxacin; systemic
2.8
17.0
99
406
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
16.9
243
1502
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
13.3
16.9
29
23
Z51.6
ICD-10 Finland
Desensitization to allergens
13.3
16.9
29
23
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
16.7
122
560
3028
Kela drug reimbursment
Mepolizumab
93.4
16.7
18
*
Z01.7
ICD-10 Finland
Laboratory examination
2.6
16.6
119
541
J01FA10
ATC
azithromycin; systemic
2.4
16.6
339
2419
R01AD01
ATC
beclometasone; nasal
2.7
16.6
110
482
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
3.5
16.3
62
198
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
6.9
15.9
25
38
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.8
15.9
52
150
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
15.8
167
904
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
15.7
216
1301
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
15.3
86
345
L50.0
ICD-10 Finland
Allergic urticaria
5.4
15.3
31
61
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
46.6
15.2
18
*
R03BB01
ATC
ipratropium bromide; inhalant
5.7
15.1
29
54
J01DC02
ATC
cefuroxime; systemic
4.0
15.0
44
117
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
15.0
82
324
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
14.9
242
1546
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
14.8
51
152
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
19.2
14.8
22
12
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
12.4
14.7
26
22
J01.1
ICD-10 Finland
Acute frontal sinusitis
6.9
14.6
23
35
S01GX01
ATC
cromoglicic acid; ophthalmic
2.3
14.6
140
723
R06AX26
ATC
fexofenadine; oral
3.2
14.6
62
212
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
14.2
117
565
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
14.1
123
608
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.7
14.1
88
372
D72.1
ICD-10 Finland
Eosinophilia
31.1
14.0
18
6
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
16.8
13.6
21
13
J32.8
ICD-10 Finland
Other chronic sinusitis
26.6
13.5
18
7
J01DB01
ATC
cefalexin; oral
2.9
13.4
419
3421
DHA10
NOMESCO Finland
Biopsy of cavity of nose
14.4
13.4
22
16
UDM02
NOMESCO Finland
Sinoscopy
6.1
13.2
23
39
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.7
13.0
31
70
L50.8
ICD-10 Finland
Other urticaria
5.8
13.0
24
43
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
14.6
12.9
21
15
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.5
12.8
47
146
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
12.8
312
2272
UDC00
NOMESCO Finland
Ear microscopy
3.4
12.7
48
152
Z88.7
ICD-10 Finland
Personal history of allergy to serum and vaccine
+∞
12.6
12
*
297, ,
Kela drug reimbursment
133.4
12.5
13
*
ZXA00
NOMESCO Finland
Right side
2.2
12.3
126
663
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
18.7
12.1
18
10
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.9
11.8
35
94
H02AB09
ATC
hydrocortisone; systemic
5.9
11.6
21
37
Z71.8
ICD-10 Finland
Other specified counselling
2.0
11.6
199
1267
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
11.5
283
2033
WX110
NOMESCO Finland
Infiltration anesthesia
2.2
11.5
373
2960
J01DA06
ATC
[U] cefuroxime
2.4
11.3
90
424
J02AC02
ATC
itraconazole; systemic
2.3
11.2
104
523
J31.0
ICD-10 Finland
Chronic rhinitis
2.7
11.1
63
252
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
10.9
113
594
DFF00
NOMESCO Finland
Pure tone audiometry
2.9
10.8
54
202
H66.9
ICD-10 Finland
Otitis media, unspecified
2.8
10.8
56
214
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
10.7
52
191
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
10.7
65
269
J02AC01
ATC
fluconazole; systemic
1.9
10.7
222
1495
J33.1
ICD-10 Finland
Polypoid sinus degeneration
61.4
10.7
12
*
A07AA02
ATC
nystatin; oral
3.7
10.7
35
101
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
10.6
74
328
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.8
10.6
24
52
Z50.1
ICD-10 Finland
Other physical therapy
3.7
10.5
34
97
J20
ICD-10 Finland
Acute bronchitis
2.6
10.5
66
278
R53
ICD-10 Finland
Malaise and fatigue
2.0
10.5
143
833
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
10.5
146
857
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
10.5
112
596
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
10.4
121
664
XF600
NOMESCO Finland
Bloodpressure measurement
3.4
10.4
38
118
XF404
NOMESCO Finland
Ambulatory ECG
3.2
10.4
42
139
T78.3
ICD-10 Finland
Angioneurotic oedema
11.6
10.1
18
16
A02BC05
ATC
esomeprazole; systemic
1.9
10.1
199
1310
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
10.1
51
192
XQ802
NOMESCO Finland
Epicutan test
3.6
10.1
34
100
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
9.9
201
1335
N02BE01
ATC
paracetamol; systemic, rectal
2.8
9.8
432
3723
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
4.0
9.8
28
73
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
13.7
9.7
16
12
J01MA06
ATC
norfloxacin; oral
2.4
9.7
72
328
A02BC02
ATC
pantoprazole; systemic
1.9
9.6
320
2473
H65.2
ICD-10 Finland
Chronic serous otitis media
9.4
9.6
19
21
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
15.4
9.6
15
10
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
7.8
9.5
21
28
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
9.4
76
359
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
7.2
9.4
22
32
Z88.2
ICD-10 Finland
Personal history of allergy to sulfonamides
+∞
9.4
9
*
R01AD11
ATC
triamcinolone; nasal
2.6
9.4
58
242
J01DA08
ATC
[U] cefaclor
2.3
9.4
76
360
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
9.3
50
194
DJD20
NOMESCO Finland
Plastic repair of septum of nose
4.0
9.3
26
67
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
9.2
106
578
X58
ICD-10 Finland
Exposure to other specified factors
2.2
9.2
91
468
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.2
9.2
19
38
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
9.1
131
772
J34.2
ICD-10 Finland
Deviated nasal septum
3.2
9.0
36
118
4224
FHL
Endonasal anthrostomy
9.7
8.8
17
18
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
8.8
165
1059
A01AB04
ATC
amphotericin B; local oral
3.7
8.8
28
79
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
8.7
154
970
R03DX10
ATC
benralizumab; systemic
50.9
8.7
10
*
3027
Kela drug reimbursment
Benralizumab
50.9
8.7
10
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
50.9
8.7
10
*
251, ,
Kela drug reimbursment
50.9
8.7
10
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.9
8.7
150
938
E66.8
ICD-10 Finland
Other obesity
2.8
8.7
44
166
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
8.6
55
233
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
8.5
22
53
N03AX16
ATC
[U] pregabalin
2.0
8.4
111
633
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
8.4
59
262
Z97.4
ICD-10 Finland
Presence of external hearing-aid
+∞
8.4
8
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
8.4
8
*
M79.6
ICD-10 Finland
Pain in limb
1.8
8.3
224
1596
R51.80
ICD-10 Finland
Headache
2.0
8.3
103
576
P06
ICPC
Sleep disturbance
2.2
8.1
79
402
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
6.5
8.1
20
32
D01
ICPC
Abdominal pain/cramps general
2.2
8.0
78
397
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.2
7.9
32
106
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
7.9
125
758
DC1AD
NOMESCO Finland
Temporalbone CT
11.1
7.8
14
13
A92
ICPC
Allergy/allergic reaction NOS
3.3
7.8
30
96
E0000UV, ,
ATC
1.7
7.8
209
1480
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
6.6
7.8
19
30
D07AC01
ATC
betamethasone; topical
1.8
7.8
174
1171
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.8
118
705
D22
ICD-10 Finland
Melanocytic naevi
2.7
7.8
41
158
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
45.7
7.7
9
*
XG405
NOMESCO Finland
Education on PEF monitoring
7.6
7.7
17
23
XG410
NOMESCO Finland
Flow-volume spirometry
3.7
7.7
24
67
R01BA01
ATC
phenylpropanolamine; oral
2.9
7.7
36
130
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
18.7
7.6
11
6
R03BB07
ATC
umeclidinium bromide; inhalant
12.1
7.6
13
11
R50.9
ICD-10 Finland
Fever, unspecified
2.1
7.6
84
449
H53.1
ICD-10 Finland
Subjective visual disturbances
2.6
7.6
43
172
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
7.5
71
357
49300
ICD-8 Finland
Asthma, bronchiale
6.1
7.5
19
32
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
81.3
7.4
8
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
8.6
7.4
15
18
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.8
7.4
36
133
A01
ICPC
Pain general/multiple sites
2.3
7.4
57
264
XQ801
NOMESCO Finland
Intracutantest
11.1
7.3
13
12
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
16.0
7.3
11
7
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
7.1
89
497
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.0
7.1
32
113
M25.5
ICD-10 Finland
Pain in joint
1.7
7.0
175
1206
N03AX12
ATC
[U] gabapentin; oral
2.0
7.0
82
447
UJF32
NOMESCO Finland
Coloscopy
1.9
7.0
107
639
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
5.6
7.0
19
35
N03AE01
ATC
clonazepam; systemic
3.0
7.0
30
103
A97
ICPC
No disease
1.9
6.9
107
640
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.3
6.9
56
264
Z2446
NOMESCO Finland
Social worker
2.6
6.9
42
174
K59.0
ICD-10 Finland
Constipation
3.1
6.9
28
93
TGC00
NOMESCO Finland
Bronchial lavation
4.2
6.9
18
44
H25.1
ICD-10 Finland
Senile nuclear cataract
2.0
6.8
77
414
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
40.6
6.8
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
6.8
56
267
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.0
6.7
29
100
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
22.9
6.7
9
*
R81
ICPC
Pneumonia
3.5
6.6
23
69
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
6.6
34
129
ZXD05
NOMESCO Finland
Urgent procedure
1.7
6.6
141
928
J01FA15
ATC
telithromycin; oral
2.2
6.6
57
276
R01AD59
ATC
mometasone, combinations; nasal
2.4
6.6
47
210
4239
FHL
Other measure in this category
14.6
6.4
10
7
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.3
6.4
24
76
JAH01
NOMESCO Finland
Laparoscopy
2.9
6.3
30
109
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
9.4
6.3
12
13
N05BB01
ATC
hydroxyzine; systemic
2.5
6.3
38
157
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
18.3
6.3
9
5
D02AE01
ATC
carbamide; topical
2.6
6.3
36
145
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.4
6.2
22
67
R08
ICPC
Nose symptom/complaint other
3.1
6.2
26
88
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.2
28
99
J01DA01
ATC
[U] cefalexin
1.6
6.2
286
2286
J01CA04
ATC
amoxicillin; systemic
1.9
6.2
402
3523
R07.0
ICD-10 Finland
Pain in throat
2.3
6.2
45
203
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
6.1
61
313
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
6.1
48
224
J01FA01
ATC
erythromycin; systemic
1.9
6.1
77
431
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
6.0
96
578
M54.5
ICD-10 Finland
Low back pain
1.6
6.0
181
1299
N30.0
ICD-10 Finland
Acute cystitis
1.9
6.0
89
524
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
6.0
54
266
A03
ICPC
Fever
1.8
6.0
100
611
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
214
337
10.74
143.85
2.2
1.2
208.25
270.58
u/ml
0.32
207
316
162
314
7.31
86.28
2.5
1.4
—
—
—
0
0
101
123
10.16
80.08
1.5
1.1
0.40
4.46
u/ml
2.54
87
70
95
107
10.85
79.81
1.5
1.1
2.42
5.13
u/ml
1.12
81
60
92
103
10.84
77.55
1.5
1.1
0.43
0.90
u/ml
0.85
77
47
89
101
10.61
74.17
1.5
1.1
0.68
1.13
u/ml
0.43
78
52
59
37
18.07
70.42
1.5
1.2
0.94
3.30
u/ml
0.44
41
19
408
2398
5.97
48.25
12.1
9.7
4.11
4.03
e9/l
0.31
352
2103
64
86
8.44
46.10
1.4
1.1
4.90
6.95
u/ml
0.25
56
35
66
97
7.74
43.99
1.4
1.0
1.59
5.10
u/ml
0.90
59
50
60
81
8.33
42.98
1.4
1.0
0.20
0.37
u/ml
0.21
49
26
100
375
3.11
20.38
2.8
2.0
52.41
34.40
u/l
0.63
83
310
200
1074
2.49
20.17
4.1
2.7
0.20
0.36
e6/l
1.35
134
764
143
659
2.67
19.81
5.1
2.9
1053.95
440.79
ng/l
0.26
89
438
216
1228
2.39
18.90
4.2
2.9
366.67
56.70
e6/l
0.72
155
910
87
344
2.87
15.90
3.0
2.2
10.63
10.45
g/l
0.15
80
320
96
407
2.70
15.33
2.3
1.7
—
—
—
0
0
253
1634
2.17
15.30
5.1
4.0
36.95
36.64
g/l
0.45
237
1551
293
2007
2.20
15.21
7.3
5.7
11.63
11.88
umol/l
0.08
281
1919
175
989
2.22
14.70
1.8
1.4
2.23
2.27
g/l
0.12
116
639
93
397
2.67
14.61
2.3
1.7
—
—
—
0
0
122
599
2.40
14.23
3.5
2.6
4.86
3.09
e6/l
0.60
47
272
218
1361
2.11
14.04
4.1
2.8
—
—
—
0
0
389
3070
2.48
13.30
5.9
4.0
11.08
10.29
mm/h
0.65
377
2896
127
658
2.27
12.95
3.4
2.5
0.90
0.98
e6/l
0.13
54
330
31
74
4.41
12.18
1.6
1.2
—
—
—
0
0
31
74
4.41
12.18
1.6
1.2
—
—
—
0
0
22
40
5.72
11.75
7.0
3.8
—
—
—
0
0
205
1315
1.98
11.67
3.6
2.9
2.36
2.36
mmol/l
0.28
189
1210
107
544
2.25
11.27
2.5
1.8
—
—
—
0
0
145
832
2.07
11.20
3.4
2.3
5.96
6.34
e6/l
0.16
128
746
92
449
2.30
10.63
3.2
2.1
4.82
8.00
umol/l
1.65
80
390
157
945
1.99
10.51
2.0
1.7
1.16
1.03
mg/l
0.09
125
735
36
107
3.56
10.49
2.1
2.2
9.64
10.54
mg/l
0.42
31
101
16
10
16.50
10.41
1.3
1.2
95.81
100.50
%
—
16
10
336
2627
1.95
9.88
6.1
4.0
166.33
1000.08
e6/l
—
6
40
234
1633
1.85
9.82
6.6
5.3
1.21
1.22
mmol/l
1.07
224
1519
460
4121
4.68
9.53
24.3
12.1
25.00
21.37
mg/l
1.24
401
3294
254
1837
1.82
9.33
7.5
5.9
1.22
1.22
mmol/l
0.02
224
1602
211
1444
1.83
9.28
4.4
3.1
26.37
30.35
u/l
2.26
200
1379
47
177
2.84
9.27
2.1
2.1
42.17
41.18
u/l
0.12
42
162
365
2970
1.99
9.09
3.9
3.0
40.06
40.98
u/l
0.11
355
2848
371
3044
2.00
8.90
10.5
7.1
75.54
77.69
u/l
0.60
361
2880
17
18
9.75
8.84
1.3
2.4
669.30
455.62
e6/l
—
10
13
183
1214
1.83
8.80
3.5
2.3
54.30
59.93
u/l
0.55
172
1138
65
297
2.38
8.67
4.3
2.9
—
—
—
0
0
256
1882
1.78
8.66
2.8
2.4
71.80
76.36
nmol/l
2.07
234
1738
26
71
3.82
8.56
1.7
1.4
—
—
—
0
0
152
964
1.85
8.38
2.8
2.3
335.72
321.89
umol/l
0.81
130
867
17
20
8.77
8.37
1.8
2.6
—
—
—
0
0
83
429
2.13
8.23
2.7
2.0
303.01
384.94
nmol/l
4.05
77
406
163
1067
1.80
8.05
1.8
1.6
—
—
—
0
0
45
183
2.61
7.67
1.8
1.6
—
—
—
0
0
120
729
1.86
7.47
3.0
2.5
2.43
2.44
mmol/l
0.26
104
662
14
18
7.98
6.65
2.0
2.5
738.64
635.11
u/ml
0.14
14
18
24
74
3.36
6.64
1.9
1.6
—
—
—
0
0
21
60
3.62
6.51
1.6
1.7
—
—
—
0
0
33
125
2.76
6.46
1.9
1.9
186.06
175.37
%
0.30
33
120
33
127
2.72
6.28
1.1
1.2
—
—
—
0
0
47
215
2.32
6.24
7.3
8.1
25.16
25.04
mmol/l
0.10
47
215
43
190
2.39
6.17
2.0
1.6
—
—
—
0
0
32
127
2.63
5.75
1.1
1.2
—
—
—
0
0
16
42
3.91
5.58
6.3
2.7
5.21
5.03
kpa
0.47
16
42
278
2242
1.58
5.50
4.1
3.3
0.00
0.00
estimate
0.50
47
448
65
355
1.96
5.50
8.3
8.3
1.44
1.00
mmol/l
0.31
52
294
88
531
1.81
5.48
2.2
2.1
2.47
2.36
g/l
0.94
80
492
269
2159
1.57
5.39
3.9
3.0
120.99
88.52
ug/l
0.53
254
2051
278
2250
1.57
5.36
4.1
3.4
31.40
0.00
estimate
0.49
48
453
280
2271
1.57
5.34
4.2
3.4
0.00
0.02
estimate
1.06
46
435
353
3026
1.65
5.30
4.4
3.4
—
—
—
0
0
16
44
3.73
5.24
1.2
1.2
—
—
—
0
0
16
44
3.73
5.24
1.2
1.2
—
—
—
0
0
92
573
1.75
5.13
2.3
2.1
13.54
13.85
umol/l
0.14
87
538
212
1627
1.55
5.10
2.2
1.9
93.87
98.52
pmol/l
0.80
115
854
19
60
3.26
5.09
1.1
1.0
1.26
1.43
g/l
1.55
19
55
25
93
2.78
5.09
2.2
2.5
—
—
—
0
0
158
1138
1.58
5.01
1.4
1.3
0.71
1.71
u/ml
1.48
33
332
275
2241
1.54
4.98
6.7
4.2
6.31
6.43
mmol/l
0.49
261
2095
49
251
2.06
4.95
3.1
3.1
81.93
71.93
ng/l
0.48
43
229
16
46
3.56
4.93
1.1
1.2
—
—
—
0
0
25
95
2.72
4.90
1.3
1.4
—
—
—
0
0
431
3935
2.03
4.89
20.2
11.4
88.13
87.73
ml/min/173m2
0.16
404
3600
38
177
2.25
4.87
1.6
1.4
—
—
—
0
0
35
158
2.31
4.82
2.0
1.7
12.87
8.47
u/ml
—
10
43
15
42
3.66
4.80
1.1
1.2
—
—
—
0
0
15
42
3.66
4.80
1.3
1.2
—
—
—
0
0
16
49
3.34
4.50
1.8
1.7
—
—
—
0
0
31
137
2.35
4.49
1.9
1.7
94.03
93.96
%
0.01
31
132
75
459
1.75
4.43
8.4
6.7
104.35
104.25
mmol/l
0.06
75
459
59
337
1.86
4.37
2.1
2.1
0.23
0.22
g/l
0.39
54
318
77
478
1.73
4.32
2.3
2.1
20.95
23.59
%
1.20
72
453
56
317
1.87
4.26
1.4
1.3
19.08
23.86
iu/l
0.62
44
276
16
51
3.21
4.24
1.2
1.2
—
—
—
0
0
380
3383
1.62
4.22
5.3
4.4
14.46
14.53
pmol/l
0.23
355
3167
25
103
2.51
4.21
2.9
3.0
2.00
1.54
index
0.24
18
52
22
87
2.60
4.02
1.6
1.4
—
—
—
0
0
229
1852
1.46
3.95
3.0
2.4
—
—
estimate
—
0
0
21
82
2.63
3.94
2.0
1.7
—
—
—
0
0
48
267
1.89
3.86
1.4
1.4
—
—
—
0
0
442
4128
2.02
3.81
24.6
13.1
3.89
3.94
mmol/l
3.93
435
4034
56
330
1.79
3.76
3.6
3.0
1.60
2.07
mmol/l
0.43
51
280
441
4121
1.98
3.71
24.3
13.1
139.54
139.68
mmol/l
0.71
436
4042
18
68
2.71
3.60
1.8
1.7
—
—
—
0
0
54
319
1.78
3.60
2.3
2.4
11.56
20.12
au/ml
—
9
27
50
289
1.82
3.58
1.3
1.3
22.54
46.00
au/ml
—
5
23
8
13
6.24
3.51
2.8
5.2
173.63
219.08
nmol/l
—
8
13
22
94
2.41
3.46
1.4
3.0
1.33
1.76
ratio
0.66
12
48
26
120
2.23
3.45
1.4
1.3
323.74
306.08
ug/g
0.15
13
72
21
88
2.45
3.44
2.1
1.7
—
—
—
0
0
13
42
3.15
3.39
1.8
1.8
—
—
—
0
0
9
18
5.07
3.38
3.1
3.6
0.89
0.72
index
—
9
18
7
10
7.08
3.37
4.3
4.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
66
2.63
3.25
2.4
2.4
0.30
0.41
iu/ml
—
10
32
421
3912
1.67
3.17
6.7
5.3
1.72
1.84
mu/l
1.64
407
3684
46
270
1.78
3.15
3.7
3.6
4.21
4.59
pmol/l
3.08
41
248
457
4356
2.30
3.15
15.5
10.4
26.28
26.04
u/l
0.12
452
4256
40
225
1.85
3.14
1.5
1.7
456.03
300.94
mu/l
0.67
33
206
75
506
1.57
3.04
1.7
1.6
1076.29
1171.72
nmol/l
0.39
54
390
28
143
2.02
2.91
1.3
1.2
—
—
—
0
0
6
9
6.73
2.87
1.3
1.0
—
—
—
0
0
18
77
2.39
2.85
1.1
1.2
2.75
7.86
u/ml
—
8
28
124
941
1.43
2.84
2.3
2.0
—
—
—
0
0
14
53
2.69
2.82
1.6
1.9
—
—
—
0
0
8
18
4.50
2.80
1.1
2.0
—
—
—
0
0
8
18
4.50
2.80
1.1
2.0
—
—
—
0
0
12
39
3.13
2.79
1.0
1.1
—
—
—
0
0
128
981
1.42
2.77
2.6
2.0
2.72
2.68
mg/l
0.07
114
851
418
3910
1.58
2.67
4.8
4.5
5.74
5.78
mmol/l
0.19
394
3652
119
910
1.41
2.60
1.4
1.3
15.83
31.91
iu/ml
3.10
34
262
9
25
3.65
2.58
1.1
1.6
—
27.80
—
0
5
44
275
1.66
2.45
1.9
2.3
67.15
67.73
g/l
0.19
38
263
57
382
1.56
2.40
1.2
1.3
163.08
143.89
u/ml
0.14
15
158
43
269
1.66
2.39
1.1
1.0
—
—
—
0
0
28
155
1.86
2.35
1.5
1.3
—
—
—
0
0
36
216
1.72
2.33
11.1
10.1
92.55
93.24
%
0.17
36
216
114
881
1.39
2.32
3.0
2.5
1423.46
832.14
ng/l
0.37
95
725
110
845
1.39
2.32
1.4
1.3
5.88
11.70
u/ml
0.78
37
343
132
1045
1.36
2.32
1.9
1.6
18.99
20.14
nmol/l
0.54
121
894
12
47
2.59
2.28
1.7
1.8
—
—
—
0
0
8
23
3.52
2.28
1.4
2.0
1.05
0.51
e9/l
—
8
23
17
79
2.19
2.27
1.2
1.2
3.00
5.15
u/ml
—
6
27
9
29
3.14
2.23
1.0
1.1
—
—
—
0
0
5
9
5.60
2.22
1.0
1.2
—
—
—
0
0
48
316
1.58
2.19
4.5
4.3
24.40
21.26
ug/l
0.06
41
265
432
4104
1.58
2.19
5.3
5.2
2.80
2.82
mmol/l
0.17
414
3877
164
1358
1.32
2.11
4.1
2.9
16.47
113.88
ng/l
1.00
89
793
115
906
1.36
2.07
1.7
1.5
—
—
—
0
0
19
101
1.92
1.83
1.0
1.1
—
—
—
0
0
203
1758
1.27
1.79
2.0
1.9
1.40
1.35
mmol/l
0.34
182
1543
32
202
1.63
1.76
1.3
1.4
276.99
251.19
miu/ml
0.12
14
107
200
1739
1.26
1.68
3.8
3.2
12.82
0.03
estimate
0.49
39
373
6
19
3.18
1.66
1.2
1.1
—
—
—
0
0
7
25
2.83
1.65
2.6
1.5
—
—
—
0
0
5
14
3.60
1.62
1.2
1.1
42.06
31.17
iu/ml
—
5
14
14
70
2.03
1.60
1.0
1.2
—
1.43
—
0
5
14
70
2.03
1.60
2.6
2.0
6.59
5.88
pmol/l
0.45
14
70
30
192
1.60
1.58
2.0
2.3
0.60
0.59
%
0.03
30
192
12
57
2.13
1.56
2.3
1.5
—
—
—
0
0
150
1271
1.26
1.55
3.8
2.7
0.00
0.01
estimate
0.78
39
359
63
473
1.38
1.54
2.0
2.1
—
—
—
0
0
406
3862
1.35
1.53
3.8
3.9
1.27
1.26
mmol/l
0.15
387
3631
398
3777
1.33
1.51
6.2
5.4
38.27
38.11
mmol/mol
0.15
385
3588
11
52
2.14
1.45
1.7
1.2
—
—
—
0
0
5
16
3.15
1.44
2.8
1.3
69.00
59.25
ug/l
—
5
16
9
39
2.33
1.43
1.0
1.3
—
—
—
0
0
10
199
0.49
1.43
1.2
1.5
—
—
—
0
0
39
274
1.46
1.38
1.2
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.96
1.36
1.2
1.0
125.40
116.71
%
—
5
17
30
201
1.53
1.33
1.7
1.5
—
—
—
0
0
423
4067
1.37
1.32
4.7
4.6
4.79
4.77
mmol/l
0.18
408
3857
422
4056
1.36
1.32
4.6
4.5
1.52
1.50
mmol/l
0.41
402
3824
13
70
1.88
1.25
1.1
1.1
—
—
—
0
0
14
78
1.82
1.22
1.1
1.2
—
—
—
0
0
32
223
1.47
1.20
1.9
2.1
4.37
7.72
ug/l
1.07
24
202
52
399
1.34
1.14
1.8
1.9
—
—
—
0
0
28
194
1.47
1.09
2.1
2.3
0.99
1.28
%
1.50
28
194
5
21
2.40
1.09
1.6
1.9
—
—
—
0
0
5
22
2.29
1.03
1.6
1.2
—
—
—
0
0
30
215
1.42
1.00
2.1
1.4
0.24
0.30
mg/l
0.35
15
92
14
84
1.69
0.99
1.2
1.3
2.39
2.74
ug/l
0.19
14
78
5
23
2.19
0.98
1.0
1.7
3.00
1.25
u/field
—
5
17
17
109
1.58
0.95
3.8
3.1
1.41
1.25
mg/l
0.62
17
99
72
598
1.24
0.89
1.8
1.7
1.39
1.40
%
0.02
63
533
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
39
303
1.31
0.83
3.1
2.3
75.37
74.22
ml/min/173m2
0.09
20
133
31
406
0.75
0.82
6.3
6.0
—
—
—
0
0
8
48
1.68
0.79
1.5
1.3
—
—
—
0
0
83
715
1.19
0.74
2.0
2.1
—
—
—
0
0
5
25
2.01
0.73
1.8
2.1
—
—
—
0
0
144
1300
1.15
0.73
3.3
3.1
7.32
8.16
mmol/l
1.34
127
1123
10
60
1.68
0.72
1.1
1.2
0.45
0.55
nmol/l
—
10
55
7
40
1.76
0.71
1.4
1.2
—
—
—
0
0
5
26
1.93
0.71
1.2
1.4
71.60
74.27
umol/l
—
5
26
7
41
1.72
0.70
1.1
1.2
1.30
1.64
nmol/l
—
7
36
89
776
1.18
0.70
2.1
2.2
—
—
—
0
0
25
187
1.36
0.69
2.7
3.5
2.24
1.82
mmol/l
0.29
19
138
34
269
1.28
0.66
2.5
2.1
12091.15
6214.32
u/l
—
10
110
5
29
1.73
0.64
3.0
1.2
—
—
—
0
0
26
199
1.32
0.64
1.6
1.5
50.96
61.25
ug/l
1.07
20
169
111
1232
0.87
0.61
3.8
3.4
0.00
0.00
estimate
0.80
46
427
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
27
210
1.30
0.60
2.3
2.2
4.28
10.26
iu/ml
—
5
45
7
111
0.63
0.58
1.3
1.5
57.40
50.09
ug/l
—
7
111
17
123
1.40
0.58
1.2
1.3
—
—
—
0
0
12
82
1.48
0.55
1.5
1.1
189.68
149.15
au/ml
—
5
22
10
66
1.53
0.53
6.6
6.6
346.40
352.09
umol/l
—
10
57
54
464
1.18
0.52
3.2
2.8
0.52
0.75
ug/l
3.16
31
277
9
136
0.66
0.52
1.4
1.7
—
—
—
0
0
111
1009
1.13
0.51
3.7
3.4
1.01
1.02
kg/l
2.93
72
654
6
41
1.47
0.50
1.0
1.3
—
—
—
0
0
12
86
1.41
0.45
1.3
1.1
—
—
—
0
0
7
51
1.38
0.44
1.0
1.0
—
—
—
0
0
5
31
1.62
0.43
1.0
1.1
—
1.11
—
0
17
5
31
1.62
0.43
1.0
1.1
132.80
115.16
pmol/l
—
5
31
5
33
1.52
0.41
3.2
1.4
2.97
6.18
umol/l
—
5
27
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
16
123
1.31
0.41
1.1
1.2
373.00
444.27
mg/l
0.79
16
115
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
8
61
1.32
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
70.25
—
0
19
9
66
1.37
0.38
1.1
1.9
—
—
—
0
0
5
37
1.35
0.37
2.0
1.5
—
—
—
0
0
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
81
740
1.11
0.36
1.7
1.6
449.33
46190164.20
pmol/l
1.22
67
643
5
80
0.62
0.35
3.2
3.4
48.20
28.01
mg/l
—
5
57
22
182
1.22
0.33
1.5
1.5
—
—
—
0
0
6
47
1.28
0.32
1.3
1.1
—
—
—
0
0
123
1155
1.09
0.32
4.3
3.9
5.97
8.36
mg/mmol
0.52
80
712
12
153
0.78
0.31
1.3
1.6
—
—
—
0
0
14
111
1.27
0.30
2.0
1.8
—
—
—
0
0
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
22
185
1.20
0.29
1.6
1.5
0.94
0.94
ratio
0.01
15
114
22
185
1.20
0.29
1.6
1.5
1.15
1.24
ratio
0.25
15
114
22
185
1.20
0.29
1.6
1.5
1.02
1.07
ratio
0.14
15
114
70
760
0.91
0.29
5.0
4.8
1.60
2.08
ug/l
0.87
65
681
65
605
1.09
0.22
1.8
1.9
3.40
3.48
ratio
0.20
48
469
16
188
0.85
0.21
1.3
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
42.21
—
0
10
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
19
219
0.86
0.21
1.2
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
16
138
1.16
0.17
2.1
2.0
1.30
5.38
iu/l
—
6
52
5
70
0.71
0.17
1.0
1.1
—
18.77
—
0
13
5
70
0.71
0.17
1.0
1.4
5.56
7.15
mmol/l
—
5
60
28
254
1.11
0.16
6.9
2.4
49.18
101.87
u/ml
0.46
28
246
49
465
1.06
0.11
1.6
1.7
3.54
3.49
mmol/l
0.12
34
334
12
108
1.11
0.07
2.0
1.7
—
—
—
0
0
60
615
0.97
0.05
4.0
4.2
20.55
21.21
%
0.10
17
272
19
194
0.98
0.00
1.3
1.1
1.00
0.90
g/l
1.26
19
194
33
333
0.99
0.00
1.6
1.5
900.66
983.91
mu/l
0.19
27
281
19
192
0.99
0.00
1.0
1.1
1.59
1.57
g/l
0.10
19
192
10
99
1.01
0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
7
75
0.93
0.00
1.6
1.5
1.10
0.87
nmol/l
—
7
63
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
8
86
0.93
0.00
1.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
6.21
—
0
8
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
76
0.92
-0.00
3.6
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_ALLERGY_DRUGS_MEDICAM_BIOLO_SUBST – Personal history of allergy to drugs, medicaments and biological substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).